The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Effect of Amitryptiline on Symptoms, Sleep, and Visceral Perception in Patients With Functional Dyspepsia
Abstract
Objective Tricyclic antidepressants in low doses are widely used in the therapy of patients with functional gastrointestinal disorders, yet the mechanism(s) of action of these drugs in these disorders is not known. In the current study, we sought to determine in a group of patients with functional dyspepsia and associated poor sleep how amitryptiline affects digestive symptoms, perceptual responses to gastric distension, and subjective and objective measures of sleep. Methods Patients were randomized to 4 wk of amitryptiline 50 mg taken at bedtime versus placebo. There was a 3-wk washout phase, followed by a cross-over to the alternate treatment. Perceptual sensitivity to gastric distention and sleep EEG were recorded at the end of each treatment period. Diaries of symptoms were maintained throughout. Results Seven of seven patients reported significantly less severe gastrointestinal symptoms after 4 wk on amitryptiline compared to placebo. Five of seven patients had evidence for altered perception of gastric balloon distension during placebo. However, the subjective symptom improvement on amitryptiline was not associated with a normalization of the perceptual responses to gastric distension. Baseline sleep dysfunction in the form of reduced sleep efficiency, increased arousal, or abnormal amounts of REM sleep was found in all seven patients. Amitryptiline significantly reduced absolute and relative amounts of REM sleep, but had no effect on sleep parameters related to nonreg…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Amitriptyline (50mg) was associated with poorer sleep efficiency for patients with functional dyspepsia, compared to placebo.
“In another study (Mertz et al., 1998), amitriptyline (50mg) was associated with poorer sleep efficiency for patients with functional dyspepsia, compared to placebo.”
From Antidepressants and their effect on sleep (2005) · cites this paper as Mertz et al., 1998
Amitriptyline (50mg) reduced REM sleep in gastroenterology patients, compared to placebo.
“(Mertz et al., 1998) found that amitriptyline (50mg) reduced REM sleep in gastroenterology patients, compared to placebo, while (Carette et al., 1995) demonstrated fewer changes in REM sleep parameters in fibromyalgia patients (dosage, 25mg).”
From Antidepressants and their effect on sleep (2005) · cites this paper as Mertz et al., 1998
Citations
Cites
Contributions of anterior cingulate cortex to behaviour
Devinsky, O., Morrell, M. J., & Vogt, B. A. (1995) · Brain · doi:10.1093/brain/118.1.279 · Cited by 3,377
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901
Flagged first, then by citations
Research works printed but not linked: 31
- Talley NJ, 1988, Ann Intern Med, 108, 865, 10.7326/0003-4819-108-6-865 · DOI
- Malagelada JR, 1993, Basic and clinical aspects of chronic abdominal pain, 55
- Bradette M, 1991, Dig Dis Sci, 36, 52, 10.1007/BF01300087 · DOI
- Mertz H, 1996, Gut
- Agreus L, 1995, Gastroenterology, 109, 671, 10.1016/0016-5085(95)90373-9 · DOI · Paper page
- Fass R, 1995, Gastroenterology, 108, A596
- David D, 1994, Gut, 35, 916, 10.1136/gut.35.7.916 · DOI
- Klein KB, 1988, Gastroenterology, 95, 232, 10.1016/0016-5085(88)90319-8 · DOI
- Greenbaum DS, 1987, Dig Dis Sci, 32, 257, 10.1007/BF01297051 · DOI
- 10.1056/NEJM199405193302003 · DOI
- Myren J, 1984, Scand J Gastroenterol, 19, 835, 10.1080/00365521.1984.12005817 · DOI
- Clouse RE, 1994, Dig Dis Sci, 39, 2352, 10.1007/BF02087651 · DOI
- Max MB, 1992, N Engl J Med, 326, 1250, 10.1056/NEJM199205073261904 · DOI
- 10.1016/0304-3959(92)90144-Z · DOI
- Silverman DHS, 1996, Gastroenterology, 110, A759
- 10.1016/S0140-6736(94)92755-3 · DOI
- 10.1016/0304-3959(95)00048-W · DOI
- Moldofsky H, 1976, Psychosom Med, 38, 35, 10.1097/00006842-197601000-00006 · DOI
- 10.1016/0304-3959(91)90047-2 · DOI
- Antidepressants Richelson E., 1990, Mayo Clin Proc, 65, 1227, 10.1016/S0025-6196(12)62747-5 · DOI
- Talley NJ, 1990, Mayo Clin Proc, 65, 1456, 10.1016/S0025-6196(12)62169-7 · DOI · Paper page
- Mertz H, 1995, Gastroenterology, 109, 40, 10.1016/0016-5085(95)90267-8 · DOI
- American Sleep Disorders Association, 1992, Sleep, 15, 174, 10.1093/sleep/15.2.174 · DOI
- Mertz H, 1995, Neurogastroenterol Motil, 7, 175, 10.1111/j.1365-2982.1995.tb00223.x · DOI
- Moldofsky H, 1989, Rheumat Dis Clin North Am, 15, 91, 10.1016/S0889-857X(21)00035-1 · DOI
- Moldofsky H, 1993, Basic and clinical aspects of chronic abdominal pain
- Goldsmith G, 1993, Dig Dis Sci, 38, 1809, 10.1007/BF01296103 · DOI
- Kumar D, 1992, Gastroenterology, 103, 12, 10.1016/0016-5085(92)91089-M · DOI
- 10.1016/0165-0173(88)90007-0 · DOI
- Reichling DB, 1988, Aratomy, physiology and pharmacology of the periaqueductal gray contribution to antinociceptive controls
- 10.1016/0304-3959(94)00142-2 · DOI
Cited by
Sorted by citations
Functional Gastroduodenal Disorders
Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J.-R., & Stanghellini, V. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.059 · Cited by 2,418
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384
Self-citationFunctional somatic syndromes: one or many?
Wessely, S., Nimnuan, C., & Sharpe, M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08320-2 · Cited by 1,211
Guidelines on the irritable bowel syndrome: mechanisms and practical management
Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N., et al. (2007) · Gut · doi:10.1136/gut.2007.119446 · Cited by 818
Drossman, D. A., Tack, J., Ford, A. C., Szigethy, E., Törnblom, H., & Van Oudenhove, L. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.279 · Cited by 470
Antidepressants and their effect on sleep
Mayers, A. G., & Baldwin, D. S. (2005) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.726 · Cited by 323
Houghton, L. A., Fell, C., Whorwell, P. J., Jones, I., Sudworth, D. P., & Gale, J. D. (2007) · Gut · doi:10.1136/gut.2006.110858 · Cited by 204
Visceral hypersensitivity and impaired accommodation in refractory diabetic gastroparesis
Kumar, A., Attaluri, A., Hashmi, S., Schulze, K. S., & Rao, S. S. C. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01081.x · Cited by 110
Serotonergic and non‐serotonergic targets in the pharmacotherapy of visceral hypersensitivity
Bueno, L., De Ponti, F., Fried, M., Kullak‐ublick, G. A., Kwiatek, M. A., Pohl, D., Quigley, E. M. M., Tack, J., & Talley, N. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00876.x · Cited by 64
Empirically supported use of psychiatric medications in adolescents and adults with IBD
Thorkelson, G., Bielefeldt, K., & Szigethy, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000734 · Cited by 39
Metadata
- Authors
- Mertz, H., Fass, R., Kodner, A., Yan-Go, F., Fullerton, S., & Mayer, E. A.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Mertz, H
- ORCID
- Venue
- American Journal of Gastroenterology
- Published
- 1998-02
- Volume
- 93
- Issue
- 2
- Pages
- 160-165
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W1975230079
- Cited by
- 220
- References
- 2
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 2 · 2015: 9 · 2014: 10 · 2013: 11 · 2012: 10
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040919, P30DK041301)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Keywords
- amitriptyline, functional dyspepsia, tricyclic antidepressants, sleep, REM sleep, gastric distension, visceral sensation, visceral sensitivity, sleep efficiency, arousal, gastrointestinal symptoms, functional gastrointestinal disorders
- MeSH terms
- Adult, Aged, Amitriptyline, Antidepressive Agents, Tricyclic, Dilatation, Double-Blind Method, Dyspepsia, Female, Humans, Male, Middle Aged, Perception, Sleep, Stomach
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review